Secretory Phospholipase A2 and Lipoprotein Lipase Enhance 15-Lipoxygenase-Induced Enzymic and Nonenzymic Lipid Peroxidation in Low-Density Lipoproteins†
- 29 May 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (25) , 9203-9210
- https://doi.org/10.1021/bi9730745
Abstract
The oxidation of low-density lipoprotein (LDL) is thought to contribute to atherogenesis. 15-Lipoxygenase (15LO) induces LDL oxidation, and phospholipase A2 enhances this process [Sparrow, C. P., Parthasarathy, S., and Steinberg, D. (1988) J. Lipid Res. 29, 745−753]. As the underlying mechanism of the enhancing effect has not been investigated previously, we here show that in the presence of soybean 15LO (SLO) or human 15LO (rhLO), the addition of lipoprotein lipase, porcine pancreatic, or human type IIa secretory phospholipase A2 (sPLA2) greatly enhanced the accumulation of hydro(pero)xides of all major classes of LDL's lipids. Hydroperoxides of free fatty acids accumulated exclusively as enzymic products with kinetics reflecting both the formation of free fatty acids and the initial ‘build-up' of α-tocopheroxyl radical. In contrast, hydroperoxides of cholesteryl esters and phosphatidylcholine accumulated linearly over comparatively longer periods of time and, in the case of rhLO, well beyond inactivation of the oxygenase. With SLO, formation of oxidized esterified lipids occurred nonenzymically, independent of the presence of lipase and despite the oxygenase remaining active until the end of the incubation. Enhancement of rhLO-induced LDL lipid peroxidation by sPLA2 was eliminated by a neutralizing anti-sPLA2 antibody, indicating that lipolytic activity was required for this effect. LDL depleted of α-tocopherol was resistant to oxidation by 15LO alone, whereas lipase overcame this resistance, demonstrating that lipases enhance 15LO-induced enzymic and nonenzymic peroxidation of LDL lipids. This is likely due to provision of free fatty acid substrate, resulting in an enhanced rate of free radical formation which itself causes nonenzymic peroxidation of esterified lipids. As lipases and 15LO are present in atherosclerotic lesions, our findings could be of pathophysiological significance.Keywords
This publication has 12 references indexed in Scilit:
- Requirement for, Promotion, or Inhibition by α-Tocopherol of Radical-Induced Initiation of Plasma Lipoprotein Lipid PeroxidationPublished by Elsevier ,1998
- Oxidation of Free Fatty Acids in Low Density Lipoprotein by 15-Lipoxygenase Stimulates Nonenzymic, α-Tocopherol-mediated Peroxidation of Cholesteryl EstersPublished by Elsevier ,1997
- Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant propertiesBritish Journal of Pharmacology, 1997
- Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitro.Journal of Clinical Investigation, 1996
- Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.Journal of Clinical Investigation, 1995
- Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density LipoproteinJournal of Biological Chemistry, 1995
- Involvement of 15-lipoxygenase in early stages of atherogenesis.The Journal of Experimental Medicine, 1994
- Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoproteinJournal of the American Chemical Society, 1993
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989